6-氟色胺盐酸盐 | 55206-24-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 6-氟色胺盐酸盐
• 中文别名: 6-氟Β-吲哚基乙胺盐酸盐；3-(2-氨乙基)-6-氟吲哚盐酸盐；6-氟β-吲哚基乙胺盐酸盐
• 英文名称: 6-fluorotryptamine hydrochloride
• 英文别名: 2-(6-fluoro-1H-indol-3-yl)ethan-1 -amine hydrochloride；6-fluorotryptammonium chloride；2-(6-fluoro-1H-indol-3-yl)ethanamine;hydron;chloride
• CAS: 55206-24-1
• 化学式: C₁₀H₁₁FN₂*ClH
• mdl: MFCD00012687
• 分子量: 214.67
• InChiKey: ODVDIBHWTMTHOS-UHFFFAOYSA-N

物化性质

• 熔点：
  233-235 °C(lit.)
• 稳定性/保质期：
  如果按照规格正确使用和储存，则不会发生分解，目前没有已知的危险反应。

计算性质

• 辛醇/水分配系数(LogP)：
  1.63
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  41.8
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37
• WGK Germany：
  3
• 海关编码：
  2933990090
• 安全说明：
  S26,S37/39
• 储存条件：
  密封，在-20°C下保存

SDS

Name:	6-Fluorotryptamine hydrochloride 99% Material Safety Data Sheet
Synonym:	6-Fluoro-1H-indole-3-ethylamine monohydrochlorid
CAS:	55206-24-1

Section 1 - Chemical Product MSDS Name:6-Fluorotryptamine hydrochloride 99% Material Safety Data Sheet
Synonym:6-Fluoro-1H-indole-3-ethylamine monohydrochlorid

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
55206-24-1	6-Fluorotryptamine hydrochloride	99	259-533-4

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.)

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 55206-24-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: very slightly beige
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 233.00 - 235.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C10H11FN2.HCl
Molecular Weight: 214.67

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 55206-24-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
6-Fluorotryptamine hydrochloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 55206-24-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 55206-24-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 55206-24-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-氟色胺盐酸盐 在 (1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diisopropylphenyl)carbamoyl)pyrrolidine-1-oxide) 、 四(3,5-二(三氟甲基)苯基)硼酸钠 、 三乙胺 、 magnesium triflate 、 三氯氧磷 作用下， 以 二氯甲烷 为溶剂， 反应 47.5h， 生成 (4S,5aR,10bS)-dimethyl 4-(4-chlorophenyl)-8-fluoro-1,2,5a,6-tetrahydropyrrolo[3',2':2,3]cyclopenta[1,2-b]indole-5,5(4H)-dicarboxylate
  参考文献：
  名称：

  通过Michael / Friedel-Crafts型级联反应构建吲哚的多环螺二氢吲哚的吲哚不对称脱芳香化作用

  摘要：

  通过手性N，N'-二氧化物/ Mg II催化剂催化2-异氰基乙基吲哚和亚烷基丙二酸酯之间的级联反应，实现了吲哚的高效不对称脱芳香化。通过Michael / Friedel-Crafts / Mannich级联反应，可以很好地获得具有三个立体中心的熔融多环二氢吲哚，并具有出色的非对映异构和对映选择性。当使用2-取代的2-异氰基乙基吲哚时，螺二氢吲哚衍生物是通过Michael / Friedel-Crafts反应获得的。

  DOI：

  10.1002/anie.201410814
• 作为产物：
  描述：

  3-fluoro-isonitrosoacetanilide 在 dimethylsulfide borane complex 、 硫酸 、 三乙胺 作用下， 以 四氢呋喃 为溶剂， 生成 6-氟色胺盐酸盐
  参考文献：
  名称：

  [EN] A NOVEL PROCESS FOR THE PREPARATION OF TRYPTAMINES AND DERIVATIVES THEREOF
  [FR] NOUVEAU PROCÉDÉ DE PRÉPARATION DE TRYPTAMINES ET DE LEURS DÉRIVÉS

  摘要：

  本发明涉及一种用于制备色胺、其取代衍生物和用于制备它们的中间体的新工艺。

  公开号：

  WO2017067670A1

文献信息

• Beta-carbolines useful for treating inflammatory disease
  申请人：Hepperle E. Michael

  公开号：US20050239781A1

  公开（公告）日：2005-10-27

  This invention provides beta-carboline compounds of formula III-A-aa: wherein Q, G, R 1 , R 2 , R 3 , and R 6b are as described in the specification. The compounds are useful for treating diseases such as inflammatory diseases and cancer.

  这项发明提供了III-A-aa式的β-咔啉化合物： 其中Q、G、R1、R2、R3和R6b如规范中所述。这些化合物可用于治疗炎症性疾病和癌症等疾病。
• SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
  申请人：Signal Pharmaceuticals, LLC

  公开号：US20150175557A1

  公开（公告）日：2015-06-25

  Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R 1 , and R 2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.

  本文提供具有以下结构的二氨基嘧啶化合物： 其中X、L、R1和R2如本文所定义，包含有效量二氨基嘧啶化合物的组合物，以及用于治疗或预防PKC-theta介导的疾病或通过抑制激酶（例如PKC-theta）可治疗或预防的疾病的方法。
• [EN] BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE<br/>[FR] BETA-CARBOLINES UTILES POUR TRAITER UNE MALADIE INFLAMMATOIRE
  申请人：MILLENNIUM PHARM INC

  公开号：WO2004092167A1

  公开（公告）日：2004-10-28

  This invention provides beta-carboline compounds of formula (I) wherein Ring A is a substituted pyridinyl, pyrimidinyl, morpholinyl, piperidinyl, piperazinyl, pyrrolidinyl, pyranyl, tetrahydrofuranyl, cyclohexyl, cyclopentyl or thiomorpholinyl ring and R1, R2 and R3 are as described in the specification. The compounds are IKK-2 inhibitors that are useful for treating IKK-2 mediated diseases such as inflammatory diseases and cancer.

  这项发明提供了式（I）中的β-咔啉化合物，其中环A是取代的吡啶基、嘧啶基、吗啉基、哌啶基、哌嗪基、吡咯啉基、吡喃基、四氢呋喃基、环己基、环戊基或硫代吗啉基环，R1、R2和R3如规范中所述。这些化合物是IKK-2抑制剂，可用于治疗IKK-2介导的疾病，如炎症性疾病和癌症。
• Access to the noryohimban [6,5,6,5,6] ring system via an intramolecular furan Diels–Alder reaction
  作者：Demosthenes Fokas、Jean E. Patterson、Gregory Slobodkin、Carmen M. Baldino

  DOI：10.1016/s0040-4039(03)01179-1

  日期：2003.6

  Polycyclic indolic compounds containing the [6,5,6,5,6] ring system were prepared via an intramolecular furan Diels–Alder reaction of α,β-unsaturated amides generated by the N-acylation of 1-(2-furyl)-β-tetrahydrocarbolines. This chemistry can provide access to D(14)-noryohimban derivatives by exploiting the functionality on the C,D,E ring system of the corresponding cycloadducts.

  含有[6,5,6,5,6]环系统的多环吲哚化合物是通过分子内呋喃Diels-Alder反应制备的，该反应由1-（2-呋喃基）-的N-酰化反应生成的α，β-不饱和酰胺β-四氢咔啉。通过利用相应环加合物的C，D，E环系统上的官能团，该化学物质可提供对D（14）-去核育亨班衍生物的访问。
• [EN] COMPOUNDS AND METHODS FOR THE MODULATION OF AhR<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LA MODULATION D'AHR
  申请人：IDEAYA BIOSCIENCES INC

  公开号：WO2019156989A1

  公开（公告）日：2019-08-15

  Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formula: (I) wherein the letters and symbols a, b, c, d, e, f, A, R1, X1, Ar1 and Ar2 have the meanings provided in the specification.

  本文提供了化合物、组合物及使用这些化合物和组合物治疗部分受AhR调控的疾病的方法。这些化合物用以下式表示：（I），其中字母和符号a、b、c、d、e、f、A、R1、X1、Ar1和Ar2的含义在规范中提供。